These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23509104)

  • 1. Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization.
    Zhang Z; He JW; Fu WZ; Zhang CQ; Zhang ZL
    J Clin Endocrinol Metab; 2013 May; 98(5):E923-33. PubMed ID: 23509104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three novel mutations in the SLCO2A1 gene in two Chinese families with primary hypertrophic osteoarthropathy.
    Cheng R; Li M; Guo Y; Yao Y; Gao C; Yao Z
    Eur J Dermatol; 2013; 23(5):636-9. PubMed ID: 24153155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and phenotypic comparison between two subtypes of primary hypertrophic osteoarthropathy (PHO): A single-center study.
    Hou Y; Lin Y; Qi X; Yuan L; Liao R; Pang Q; Cui L; Jiang Y; Wang O; Li M; Dong J; Xia W
    Bone; 2018 Jan; 106():96-102. PubMed ID: 28963081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy.
    Zhang Z; Xia W; He J; Zhang Z; Ke Y; Yue H; Wang C; Zhang H; Gu J; Hu W; Fu W; Hu Y; Li M; Liu Y
    Am J Hum Genet; 2012 Jan; 90(1):125-32. PubMed ID: 22197487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
    Diggle CP; Parry DA; Logan CV; Laissue P; Rivera C; Restrepo CM; Fonseca DJ; Morgan JE; Allanore Y; Fontenay M; Wipff J; Varret M; Gibault L; Dalantaeva N; Korbonits M; Zhou B; Yuan G; Harifi G; Cefle K; Palanduz S; Akoglu H; Zwijnenburg PJ; Lichtenbelt KD; Aubry-Rozier B; Superti-Furga A; Dallapiccola B; Accadia M; Brancati F; Sheridan EG; Taylor GR; Carr IM; Johnson CA; Markham AF; Bonthron DT
    Hum Mutat; 2012 Aug; 33(8):1175-81. PubMed ID: 22553128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype-genotype correlation in Japanese patients with pachydermoperiostosis.
    Sasaki T; Niizeki H; Shimizu A; Shiohama A; Hirakiyama A; Okuyama T; Seki A; Kabashima K; Otsuka A; Ishiko A; Tanese K; Miyakawa S; Sakabe J; Kuwahara M; Amagai M; Okano H; Suematsu M; Kudoh J
    J Dermatol Sci; 2012 Oct; 68(1):36-44. PubMed ID: 22906430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel mutations in the SLCO2A1 gene in a Chinese patient with primary hypertrophic osteoarthropathy.
    Zhang Z; He JW; Fu WZ; Zhang CQ; Zhang ZL
    Gene; 2014 Jan; 534(2):421-3. PubMed ID: 24185079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biochemical characteristics of 12 Chinese primary hypertrophic osteoarthropathy patients with HPGD mutations.
    Lu Q; Xu Y; Li S; Zhang Z; Sheng J; Zhang Z
    Int J Biol Sci; 2022; 18(9):3908-3917. PubMed ID: 35813463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the prostaglandin transporter encoding gene SLCO2A1 cause primary hypertrophic osteoarthropathy and isolated digital clubbing.
    Seifert W; Kühnisch J; Tüysüz B; Specker C; Brouwers A; Horn D
    Hum Mutat; 2012 Apr; 33(4):660-4. PubMed ID: 22331663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, Biochemical, and Genetic Features of 41 Han Chinese Families With Primary Hypertrophic Osteoarthropathy, and Their Therapeutic Response to Etoricoxib: Results From a Six-Month Prospective Clinical Intervention.
    Li SS; He JW; Fu WZ; Liu YJ; Hu YQ; Zhang ZL
    J Bone Miner Res; 2017 Aug; 32(8):1659-1666. PubMed ID: 28425581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy.
    Xu Y; Zhang Z; Yue H; Li S; Zhang Z
    J Bone Miner Res; 2021 Aug; 36(8):1459-1468. PubMed ID: 33852188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the Mutations in the Prostaglandin Transporter Gene, SLCO2A1 and Clinical Characterization in Korean Patients with Pachydermoperiostosis.
    Lee S; Park SY; Kwon HJ; Lee CH; Kim OH; Rhee Y
    J Korean Med Sci; 2016 May; 31(5):735-42. PubMed ID: 27134495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two cases of primary hypertrophic osteoarthropathy with SLCO2A1 gene mutations].
    Jin P; Zhang Q; He H; Zhu W; Long X; Mo Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 43(1):100-105. PubMed ID: 30154299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance.
    Guda K; Fink SP; Milne GL; Molyneaux N; Ravi L; Lewis SM; Dannenberg AJ; Montgomery CG; Zhang S; Willis J; Wiesner GL; Markowitz SD
    Cancer Prev Res (Phila); 2014 Aug; 7(8):805-12. PubMed ID: 24838973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Common Mutation and a Novel Mutation in the HPGD Gene in Nine Patients with Primary Hypertrophic Osteoarthropathy.
    Yuan L; Chen L; Liao RX; Lin YY; Jiang Y; Wang O; Li M; Xing XP; Pang QQ; Jiajue R; Xia WB
    Calcif Tissue Int; 2015 Oct; 97(4):336-42. PubMed ID: 26135126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two novel mutations in the SLCO2A1 prostaglandin transporter gene in a Chinese patient with primary hypertrophic osteoarthropathy.
    Guo T; Yang K; Liu L; Tan ZP; Luo H
    Mol Med Rep; 2017 May; 15(5):2977-2982. PubMed ID: 28339061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in the SLCO2A1 gene in a Chinese family with primary hypertrophic osteoarthropathy.
    Zhang Z; He JW; Fu WZ; Zhang CQ; Zhang ZL
    Gene; 2013 May; 521(1):191-4. PubMed ID: 23531451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel SLCO2A1compound heterozygous mutation causing primary hypertrophic osteoarthropathy with Bartter-like hypokalemia in a Chinese family.
    Jiang Y; Du J; Song YW; Wang WB; Pang QQ; Li M; Wang O; Lian XL; Xing XP; Xia WB
    J Endocrinol Invest; 2019 Oct; 42(10):1245-1252. PubMed ID: 31004291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the prostaglandin transporter SLCO2A1 cause primary hypertrophic osteoarthropathy with digital clubbing.
    Busch J; Frank V; Bachmann N; Otsuka A; Oji V; Metze D; Shah K; Danda S; Watzer B; Traupe H; Bolz HJ; Kabashima K; Bergmann C
    J Invest Dermatol; 2012 Oct; 132(10):2473-2476. PubMed ID: 22696055
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary hypertrophic osteoarthropathy related gastrointestinal complication has distinctive clinical and pathological characteristics: two cases report and review of the literature.
    Wang Q; Li YH; Lin GL; Li Y; Zhou WX; Qian JM; Xia WB; Wu D
    Orphanet J Rare Dis; 2019 Dec; 14(1):297. PubMed ID: 31878983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.